Peptides for Healing: What BPC-157, TB-500 and GHK-Cu Do, and How Strong the Evidence Is
BPC-157, TB-500 and GHK-Cu are the most studied healing peptides. Their repair effects are consistent in animal and cell studies, no human randomized trial has confirmed them for injury, and as of late 2026 the first two still cannot legally be compounded in the U.S.
Key takeaways
- The three most studied healing peptides are BPC-157 (gut-derived, angiogenesis and tendon repair), TB-500 (thymosin beta-4 fragment, cell migration) and GHK-Cu (copper tripeptide, collagen and skin repair).
- Every BPC-157 study to date has shown positive healing effects, but almost all are in rodents; there is no completed human randomized trial for musculoskeletal injury.[9]
- In rats, BPC-157 fully restored transected Achilles tendons: higher load to failure, better function and organized collagen versus controls.[1]
- GHK-Cu plasma levels fall from about 200 ng/mL at 20 to 80 ng/mL at 60, and the peptide regulates collagen, elastin and repair-gene expression in laboratory studies.[5]
- As of late 2026, BPC-157 and TB-500 are off the FDA's Category 2 list but still cannot legally be compounded, so product quality, not the molecule, is the main real-world risk.
What are healing peptides?
Healing peptides are short chains of amino acids (typically 2 to 50) that act as signaling molecules, telling cells to repair tissue, calm inflammation, grow new blood vessels or release growth factors. The three most studied for tissue repair are BPC-157, TB-500 (thymosin beta-4) and GHK-Cu, and for all three the evidence is strong in animal models and still thin in humans. They're the body's internal messengers, telling cells to repair tissue, calm inflammation, release hormones, or mount an immune response.
Your body already makes thousands of peptides. Insulin is a peptide. Oxytocin is a peptide. Growth hormone-releasing hormone is a peptide. Therapeutic peptide therapy works with this existing signaling system. It provides specific peptides in concentrated form to amplify particular biological processes, especially tissue repair and regeneration.
Three peptides have stood out in regenerative medicine: BPC-157 (Body Protection Compound-157), TB-500 (a synthetic fragment of Thymosin Beta-4), and GHK-Cu (glycyl-L-histidyl-L-lysine copper complex). They each work through different mechanisms, but they often complement each other, which is why physicians frequently combine them in treatment protocols.
What is BPC-157, and what does it do for healing?
BPC-157 is a 15-amino acid peptide originally isolated from human gastric juice, which is a strange origin story for something with such broad healing effects. Despite coming from the stomach, BPC-157 has shown broad regenerative properties across nearly every tissue type researchers have tested: tendons, ligaments, muscle, bone, intestinal lining, and nervous tissue.[1]
Key Properties
- •Angiogenesis: Promotes formation of new blood vessels, increasing nutrient and oxygen delivery to damaged tissue
- •Growth factor modulation: Upregulates VEGF, EGF, and growth hormone receptors, creating a pro-healing environment
- •Anti-inflammatory: Modulates the nitric oxide system and reduces pro-inflammatory cytokines
- •Neuroprotective: Research demonstrates protective effects on neural tissue, including potential benefits for gut-brain axis function
- •Gut healing: Originally studied for gastrointestinal conditions, BPC-157 has strong evidence for healing intestinal damage, including NSAID-induced damage
- •Tendon and ligament repair: One of the most studied applications, with multiple animal studies demonstrating accelerated healing
How BPC-157 Is Used
BPC-157 is most commonly administered via subcutaneous injection, either systemically (abdominal area) or locally near the injury site. Oral formulations exist and may be preferred for gastrointestinal applications. Treatment protocols typically run 6–12 weeks, with dosing determined by the physician based on the condition being treated.[2]
For detailed information on BPC-157 for specific conditions, see our guides on peptides for tendon repair and peptides for arthritis.
What is TB-500 (thymosin beta-4)?
TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a 43-amino acid peptide found in virtually every cell in your body. Scientists originally flagged it for its role in immune function, but it turned out to be far more versatile than expected. It's now recognized as a critical player in tissue repair, cell migration, and inflammation resolution.[3]
Key Properties
- •Cell migration: TB-500 upregulates actin, the protein that forms cell structural frameworks, enabling faster migration of repair cells to injury sites
- •Anti-inflammatory: Potent reducer of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), addressing the chronic low-grade inflammation that impedes healing
- •Stem cell activation: TB-500 activates resident stem cells in damaged tissue, promoting differentiation into functional cells
- •Extracellular matrix remodeling: Supports production and organization of the extracellular matrix critical for tissue structural integrity
- •Blood vessel formation: Promotes angiogenesis through mechanisms complementary to BPC-157
- •Cardiac protection: Research demonstrates cardioprotective effects, including support for cardiomyocyte survival after cardiac events
BPC-157 + TB-500: The Healing Stack
One of the most common peptide protocols combines BPC-157 and TB-500, taking advantage of their complementary mechanisms. BPC-157 excels at vascular repair and growth factor stimulation, while TB-500 specializes in inflammation resolution and cell mobilization. Together, they address multiple aspects of the healing cascade simultaneously.[6]
What is GHK-Cu, and why is it called regenerative?
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide first identified in human plasma. What makes it especially interesting from an aging perspective: GHK-Cu levels drop dramatically over a lifetime, from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60. That decline maps closely to the loss of regenerative capacity we associate with getting older.[5]
Key Properties
- •Collagen synthesis: Stimulates production of collagen types I and III, supporting structural tissue integrity
- •Gene expression modulation: Research shows GHK-Cu modulates expression of over 4,000 human genes, upregulating repair genes and downregulating destructive/inflammatory genes
- •Antioxidant: Protects tissues from oxidative damage, a key driver of aging and degenerative disease
- •Glycosaminoglycan production: Promotes production of proteoglycans essential for cartilage and connective tissue health
- •Wound healing: Extensively studied for skin wound healing, with applications extending to deeper tissue repair
- •Anti-aging: Broad regenerative effects position GHK-Cu as one of the most researched anti-aging peptides
GHK-Cu is used both topically (skin health) and systemically (subcutaneous injection for broader regenerative effects). It is a key peptide in our arthritis management protocols and connects closely with collagen peptide therapy.
How do healing peptides work?
Healing peptides work by amplifying the three phases of your body's own repair cascade: modulating inflammation, driving proliferation (new blood vessels, fibroblasts, collagen), and organizing the remodeling phase. What makes them different from most pharmaceuticals is that they work through your body's own signaling infrastructure. They don't introduce foreign chemistry. They turn up the volume on repair processes that are already running:
The Healing Cascade
- •Inflammation phase: TB-500 and BPC-157 modulate the inflammatory response so it does its job without turning chronic or destructive
- •Proliferation phase: BPC-157 stimulates angiogenesis and fibroblast proliferation. GHK-Cu promotes collagen synthesis. TB-500 mobilizes repair cells.
- •Remodeling phase: GHK-Cu supports extracellular matrix organization. BPC-157 promotes organized collagen alignment. TB-500 helps prevent excessive scarring.
The combination of these peptides addresses all three phases of tissue repair, which is why multi-peptide protocols often produce better outcomes than single-peptide approaches.
What conditions might healing peptides help?
Healing peptides are used for slow-healing connective-tissue problems: tendon and ligament injuries, joint and cartilage degeneration, muscle strains, gut-lining damage, post-surgical recovery and wound healing. In our clinical experience, and based on the published research, peptide therapy has shown promise for patients dealing with:
- •Tendon injuries: Tendinopathy, partial tears, post-surgical tendon repair
- •Joint health: Osteoarthritis, inflammatory arthritis, cartilage degeneration
- •Muscle injuries: Strains, tears, post-surgical muscle repair
- •Gut health: Inflammatory bowel conditions, leaky gut, NSAID-induced gastrointestinal damage
- •Post-surgical recovery: Accelerating healing after orthopedic or soft tissue surgery
- •Chronic inflammation: Persistent low-grade inflammation that impedes healing and recovery
- •Sports injuries: Full recovery support for athletic injuries
- •Age-related degeneration: Supporting tissue maintenance and repair capacity that declines with aging
Which guide should you read for your condition?
We've put together detailed guides for each major application of peptide therapy. Each one covers the relevant peptides, what the clinical evidence actually shows, how treatment protocols work, and what you can realistically expect:
Peptides for Tendon Repair
BPC-157 and TB-500 for accelerating tendon healing, treating tendinopathy, and supporting post-surgical recovery.
Peptides for Libido
PT-141 (bremelanotide) for addressing low sexual desire through central nervous system pathways. FDA status and comparison to PDE5 inhibitors.
Peptides for Sleep
DSIP (Delta Sleep-Inducing Peptide) for improving sleep architecture and supporting deep, restorative sleep.
Peptides for Belly Fat
GH secretagogues (Ipamorelin, CJC-1295, Tesamorelin) for targeting visceral fat and improving body composition.
Peptides for Muscle Growth
GH secretagogues for lean mass development: how they differ from steroids and support safe, sustainable muscle growth.
Peptides for Arthritis
BPC-157, TB-500, and GHK-Cu for managing joint pain, inflammation, and supporting cartilage health.
Collagen Peptides
Understanding collagen peptide supplementation vs. clinical-grade collagen, collagen types I/II/III, and their roles in structural health.
How strong is the clinical evidence for healing peptides?
The evidence for healing peptides is consistently positive in animal and cell studies and still unconfirmed in humans: there is no completed human randomized controlled trial of BPC-157 or TB-500 for musculoskeletal injury. The evidence ranges from a deep body of preclinical data to a smaller set of human clinical evidence:
“Currently, all studies investigating BPC 157 have demonstrated consistently positive and prompt healing effects for various injury types, both traumatic and systemic and for a plethora of soft tissues. However, to date, the majority of studies have been performed on small rodent models and the efficacy of BPC 157 is yet to be confirmed in humans.”
| Peptide | Best-studied effects | Human evidence | U.S. status (late 2026) |
|---|---|---|---|
| BPC-157 | Tendon, ligament, muscle and gut healing; angiogenesis | No completed randomized trials; rodent data[1][9] | Off FDA Category 2; not yet compoundable |
| TB-500 / thymosin β4 | Cell migration, wound and corneal healing | Small trials of full Tβ4 (dry eye, wounds)[3][4] | Not approved; not compoundable |
| GHK-Cu | Collagen synthesis, skin repair, gene expression | Topical cosmetic use; wound-healing studies[5] | Topical cosmetics available; injectable off Category 2 |
BPC-157
BPC-157 has the largest body of preclinical evidence, with hundreds of published studies across tissue types. Key findings include accelerated healing of tendons, ligaments, muscle, bone, and gastrointestinal tissue in animal models. Human clinical trials are limited but ongoing.[7]
TB-500 / Thymosin Beta-4
TB-500 research includes both animal studies and human clinical data, particularly in wound healing and cardiac applications. Thymosin Beta-4 has been evaluated in clinical trials for corneal healing, cardiac repair, and wound management.[4]
GHK-Cu
GHK-Cu has extensive research supporting its regenerative properties, with gene expression studies revealing modulation of over 4,000 genes. Clinical use in dermatology has established a strong safety record, and broader regenerative applications are being explored.[5]
How does Strong Health approach healing peptides?
At Strong Health, every peptide therapy protocol follows a structured clinical framework:
- •Thorough evaluation: Medical history, physical examination, relevant imaging, and baseline lab work
- •Goal alignment: Clear discussion of treatment goals, expected timelines, and realistic outcomes
- •Individualized protocol: Physician designs a peptide protocol tailored to the patient's specific condition, health status, and goals
- •Quality assurance: All peptides are sourced from licensed compounding pharmacies with verified purity and potency
- •Patient education: Thorough training on self-administration technique, dosing schedule, and what to monitor
- •Ongoing monitoring: Regular follow-up appointments to assess progress, adjust protocols, and monitor for any adverse effects
- •Integrated care: Peptide therapy is coordinated with other treatments (physical therapy, nutrition, exercise) for optimal outcomes
Are healing peptides safe?
Healing peptides have shown a wide safety margin in animal studies and mostly mild, transient effects (injection-site irritation, headache) in clinical use, but human safety data are limited and product quality is the biggest real-world risk. Safety comes down to three things: peptide quality, appropriate dosing, and physician oversight.
Why Physician Supervision Matters
- •Proper diagnosis: Ensuring the underlying condition is correctly identified before treatment selection
- •Contraindication screening: Identifying conditions that may make peptide therapy inappropriate (active cancer, certain autoimmune conditions, pregnancy)
- •Drug interaction review: Evaluating potential interactions with current medications
- •Dosing optimization: Starting at appropriate doses and adjusting based on individual response
- •Quality assurance: Prescribing from licensed pharmacies rather than unregulated sources
- •Monitoring: Regular assessment of both therapeutic response and potential adverse effects
For patients interested in specific applications, explore our detailed guides: tendon repair, libido, sleep, belly fat, muscle growth, arthritis, and collagen peptides. You can also browse the complete peptide therapy hub for every protocol we offer.
Active patients recovering from soft-tissue injuries can start treatment locally with peptide therapy in Atlanta.
Frequently Asked Questions
What are peptides used for in medicine?
Are healing peptides FDA-approved?
How are peptides administered?
How long does peptide therapy take to work?
Can multiple peptides be used together?
Are peptides safe?
How much does peptide therapy cost?
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided has been reviewed by licensed healthcare professionals but individual results may vary.
Related Articles
Molecules in this guide
Browse the molecule library →Each peptide below has a physician-reviewed page covering what it is, the evidence, and how Strong Health prescribes it.
Peptide therapy near you
View all locations →Physician-supervised peptide therapy from our Miami (Brickell) clinic and via telehealth across 17 metros. Pick the location nearest you.
Interested in Peptide Therapy?
Our physician team evaluates your health goals and determines if peptide therapy is right for you. Every protocol is individualized and physician-supervised.
References & Citations
- Seiwerth S, et al. BPC 157 and standard angiogenic growth factors: Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr Pharm Des. 2018;24(18):1972-1989.
- Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications. Curr Neuropharmacol. 2016;14(8):857-865.
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368.
- Sosne G, et al. Thymosin beta 4 promotes dermal healing. Vitam Horm. 2016;102:251-275.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
- Huff T, et al. Beta-thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001;33(3):205-220.
- Vuksic T, Zoricic I, Brcic L, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease. World J Gastroenterol. 2021;27(15):1584-1602.
- Junnila RK, et al. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013;9(6):366-376.
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159.